Qlucore
- Company typePublic
- Founded2007
- HeadquartersLund, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Qlucore firmographics
Firmographics- Name
- Qlucore
- Legal name
- Qlucore AB
- Website
- https://qlucore.com
- Company type
- Public
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Qlucore industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
Keywords
Where Qlucore is headquartered
LocationHeadquarters
- HQ city
- Lund
- HQ country
- Sweden
- HQ region
- Europe
Offices3 records
Markets served
Qlucore business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Software Licenses and Subscriptions: Qlucore generates revenue through software licensing of Qlucore Omics Explorer and Qlucore Insights, with subscription-based pricing models. The company offers free trials for evaluation purposes.
- Clinical Diagnostics Software: Qlucore Diagnostics generates revenue from CE-marked IVDR-certified diagnostic tests sold to clinical laboratories and hospitals for clinical cancer diagnostics.
- Cloud Services: Cloud-based access to Qlucore Omics Explorer with computational power and centralized data storage, offered in Standard, Performance, and NGS packages.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free trial available for evaluation |
| Subscription | Monthly | Cloud packages with computational power and storage |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Qlucore product offering
Product offeringCore offering
Qlucore develops and sells visualization-based bioinformatics software for multi-omics data analysis and clinical cancer diagnostics. Its product family spans Qlucore Omics Explorer (desktop/cloud research software with interactive visualization and integrated statistics), Qlucore Insights (research-use AI classifiers and gene fusion detection for cancer subtyping), and Qlucore Diagnostics (CE-marked IVDR-certified clinical diagnostic software). The company also offers AWS-hosted cloud deployment of its software.
Product overview
Qlucore offers a three-tier product portfolio centered on visualization-based bioinformatics software for omics research and precision diagnostics. The flagship platform is Qlucore Omics Explorer, a desktop and cloud software enabling multi-omics data analysis with interactive visualizations, integrated statistics (DESeq2, ANOVA, t-tests), machine learning classifiers, and a Python-based Templates scripting system, with an optional NGS Module add-on for genome browsing and fusion analysis. On top of this platform, Qlucore Insights (Research Use Only) provides disease-specific AI-powered classifiers and gene fusion detection for four cancer types: BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer — each available as separate disease models within the same software. The third tier, Qlucore Diagnostics, is the CE-marked IVDR-certified clinical version, with the first product being the Qlucore Diagnostics BCP-ALL test for pediatric leukemia, while AML and bladder cancer tests remain under development. All products are sold as software licenses with optional cloud deployment on AWS.
Differentiator
Problem solved
Functional benefit
Brands
- Qlucore Omics Explorer: Powerful, flexible and easy-to-use visualization of multi-omics data for fast analysis and results. Used by researchers and pharmaceutical companies worldwide.
- Qlucore Insights
- Qlucore Diagnostics
Products and services
- Qlucore Omics Explorer Powerful, flexible, and easy-to-use visualization-based software for multi-omics data analysis, supporting genomics, proteomics, transcriptomics, and single-cell data. It features real-time interactive plots (PCA, UMAP, t-SNE, heatmaps, volcano plots, violin plots), integrated DESeq2 statistics, machine learning classifiers, Python-based Templates scripting, and optional cloud deployment. It is used by researchers and pharmaceutical companies across 20-25 countries.
- Qlucore Insights Disease-specific research-use-only (RUO) software platform combining AI-based machine learning classifiers with gene fusion detection for tumor subtype classification. Supports models for BCP-ALL, AML, lung cancer, and urothelial (bladder) cancer, providing automated PDF reports with results, plots, quality metrics, and method information for researchers and pharmaceutical users.
- Qlucore Diagnostics IVDR-certified (CE-marked) in vitro diagnostic software for clinical use in hospitals. The first product is Qlucore Diagnostics BCP-ALL, a CE-marked RNA-seq based diagnostic test for pediatric Acute Lymphoblastic Leukemia, providing gene expression subtype classification and gene fusion analysis support. CE-marked tests for AML and bladder cancer are in development. Sold directly to hospitals and clinical diagnostic laboratories.
- Qlucore Cloud Services Cloud-hosted deployment of Qlucore Omics Explorer accessible from any internet-connected device, operated on Amazon Web Services (AWS). Available packages include Standard (for most omics data including RNA-seq, 20GB storage), Performance (for single cell RNA-seq, 50GB storage), and NGS (for omics, NGS, and genomic analysis). Sold as monthly subscriptions.
Quantifiable outcome
- Up to 7% more samples covered compared to standard methods in BCP-ALL through detection of DUX4-rearranged and ETV6::RUNX1-like subtypes
- +4 more outcomes
Companies that use Qlucore
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Qlucore technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration9 records
AI capability3 records
Feature5 records
Qlucore partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Rigshospitalet, DenmarkcoreDenmark's largest teaching and public hospital uses Qlucore Diagnostics BCP-ALL for clinical diagnostics of pediatric leukemia. Rigshospitalet was an early adopter, transitioning from Qlucore Insights RUO to the CE-marked IVDR-compliant solution.
- Heidelberg University HospitalcoreCollaboration through Eurostars program resulted in lung classifier model for AI-based lung cancer subtyping. Results presented as poster at MAP Congress 2024 in London, demonstrating high accuracy in analyzing lung tumors and lung diseases.
- FNCA Sweden ABminorCertified Advisor for Qlucore's listing on Nasdaq First North Growth market. Located at Nybrogatan 34, 102 45 Stockholm, Sweden.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Qlucore competitors and assessment
Company assessmentDirect peers
- Velsera (formerly Seven Bridges Genomics): Provides a genomics and multi-omics analytics platform for research, pharma, and clinical customers, including pipelines for RNA-seq and cancer analysis. Comparable to Qlucore's platform plus Insights/Diagnostics portfolio.
- Genedata: Enterprise bioinformatics platform for omics data analysis, biopharma R&D workflows, and large-scale screening. Comparable to Qlucore as a specialist omics-software vendor targeting pharma/biotech customers with sophisticated analytics.
- DNAnexus: Cloud-based biomedical data analysis and informatics platform supporting clinical and research genomics. Comparable to Qlucore on the cloud bioinformatics side, especially given Qlucore's AWS-based Cloud Hub offering.
- Partek: Provides Partek Flow, a commercial bioinformatics software suite for NGS and multi-omics analysis with visualization and statistical workflows. Directly comparable to Qlucore Omics Explorer as a paid desktop/cloud bioinformatics platform serving research and pharma customers.
- SOPHiA Genetics: Offers the SOPHiA DDM platform for clinical genomics data analysis, including CE-IVD algorithms for cancer and rare disease. Directly comparable to Qlucore Diagnostics as a regulated, software-driven clinical genomics/diagnostic analytics vendor.
Broad incumbents
- Thermo Fisher Scientific: Major life sciences tools and informatics company offering Ion Torrent, Oncomine assays, and bioinformatics/analytics tools. A broad incumbent competing with Qlucore across research and clinical oncology workflows.
- Illumina: Dominant NGS instrument and informatics provider with DRAGEN, BaseSpace, and connected analytics offerings. A broad incumbent that competes with Qlucore's software across research and clinical genomics customers.
Emerging players
- BlueBee: Cloud bioinformatics and genomics data-analysis platform serving clinical and research labs across Europe. Comparable to Qlucore on cloud-delivered bioinformatics for regulated and research use.
- PierianDx (now part of Philips): Clinical genomics interpretation platform for oncology and hereditary disease, integrated into Philips' broader diagnostics portfolio. Comparable to Qlucore Diagnostics as a clinical genomics interpretation vendor focused on hospitals.
- ROSALIND (OnRamp Bioinformatics): Cloud-based bioinformatics platform for genomics and multi-omics analysis aimed at research and translational customers. Comparable to Qlucore Omics Explorer Cloud as a SaaS-style omics analysis offering.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Qlucore social profiles
Digital presenceQlucore compliance and trust
Trust signalCompliance3 records
Qlucore financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qlucore leadership team
Management profileNumber of profiles
Profiles9 records
Qlucore funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qlucore M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qlucore
What does Qlucore do?
Qlucore develops and sells visualization-based bioinformatics software for multi-omics data analysis and clinical cancer diagnostics. Its product family spans Qlucore Omics Explorer (desktop/cloud research software with interactive visualization and integrated statistics), Qlucore Insights (research-use AI classifiers and gene fusion detection for cancer subtyping), and Qlucore Diagnostics (CE-marked IVDR-certified clinical diagnostic software). The company also offers AWS-hosted cloud deployment of its software.
Is Qlucore a public or private company?
Qlucore is a public company. It is classified as public and is currently operating.
When was Qlucore founded?
Qlucore was founded in 2007. It employs 11 to 50 people.
Where is Qlucore based?
Qlucore is headquartered in Lund, Sweden, in the Europe region.
How does Qlucore make money?
Three revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are clinical Diagnostics Software and cloud Services.
Who are Qlucore's main competitors?
Direct peers on record are Velsera (formerly Seven Bridges Genomics), Genedata, DNAnexus, Partek and SOPHiA Genetics. Broad incumbents are Thermo Fisher Scientific and Illumina. Emerging players are BlueBee, PierianDx (now part of Philips) and ROSALIND (OnRamp Bioinformatics).
Does Qlucore have an API?
No public API is recorded for Qlucore.
What industry is Qlucore in?
Qlucore's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAF, Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D). Its NAICS code is 5132 and its SIC code is 7372.